[Knowledge of the cost of the treatments delivered from the Hospital Pharmacy Department and perception of the health status]. / Conocimiento del coste de los tratamientos dispensados desde el servicio de farmacia hospitalaria y percepción del estado de salud.

OBJECTIVE: To assess the influence of the knowledge of the financial cost of the treatment and perception of the patient of his/her health status and the health care received from the Hospital Pharmacy Department (HPD). METHOD: During a four-month period, from July to October of 2009, a questionnaire was provided to all the patients coming to the Hospital Pharmacy Department to gather their medications, except for those starting their therapies. The patients returning the completed questionnaire at a next visit were provided with the second part, in which they were informed on the monthly cost of their treatments and some questions from the main questionnaire were asked again. RESULTS: 682 questionnaires were provided, of which 240 (35.3%) were returned completed. 223 patients were given the second part, of which 151 (22.1%) were returned. In general, the patients were satisfied with their treatments (90.4%) and with the care provided at the HPD (95.4%), 69.2% had good knowledge of their treatment, and 59.2% considered themselves as good compliers, and 17.5% did not usually consult with the pharmacist at the HPD. The patient's satisfaction analysis before (7.75; SD: 1.90) and after knowing the treatment cost (7.80; SD: 1.91) did not show statistically significant differences, with the exception of those patients derived from the Infectious Disease Department (p = 0.015) that were less satisfied after knowing the cost. CONCLUSIONS: The knowledge on the treatment cost could not be related in general with changes in the attitude of the patients towards their treatments, being necessary the design of more profound studies. Besides, it should be recommended to undertake the improvement actions detected by the patients in order to increase the quality of the pharmacy care delivered.

Conocimiento del coste de los tratamientos dispensados desde el Servicio de Farmacia Hospitalaria y percepción del estado de salud / Knowledge of the cost of the treatments delivered from the Hospital Pharmacy Department and perception of the health status

Objetivo: Valorar la influencia del conocimiento del coste económico del tratamiento sobre la percepción del paciente de su estado de salud y la atención recibida en el Servicio de Farmacia Hospitalaria (SFH). Método: Durante un periodo de cuatro meses, de julio a octubre de 2009, se entrega una encuesta a todos los pacientes que acuden a recoger medicación al Servicio de Farmacia Hospitalaria (SFH), excepto a los que inician el tratamiento. A los pacientes que devuelven la encuesta principal cumplimentada en una visita posterior, se les hace entrega de la segunda parte, en la que se les informa del coste mensual de su tratamiento y se reformulan preguntas de la encuesta principal. Resultados: Son repartidas 682 encuestas, de las cuales son contestadas 240 (35,3%). Se entrega la segunda parte de la encuesta a 223 pacientes, de las que se devuelven 151 (22,1%). En general, los pacientes están satisfechos con el tratamiento (90,4%) y con la atención recibida en el SFH (95,4%), tienen un buen conocimiento del tratamiento (69,2%), se consideran cumplidores (59,2%%) y no suelen consultar al farmacéutico del SFH (17,5%). En el análisis de la satisfacción del paciente antes (7,75; DE: 1,90) y después de conocer el coste del tratamiento (7,80; DE: 1,91) no se han encontrado diferencias estadísticamente significativas, excepto en los pacientes derivados desde la Unidad de Enfermedades Infecciosas (p = 0,015), menos satisfechos tras conocer el coste. Conclusiones: No se ha podido relacionar el conocimiento del coste del tratamiento, en rasgos generales, con cambios en la actitud de los pacientes frente al mismo, siendo necesario el diseño de estudios más amplios. Asimismo, sería recomendable acometer los puntos de mejora detectados por los pacientes para elevar la calidad de la Atención Farmacéutica ofrecida (AU)

Objective: To assess the influence of the knowledge of the financial cost of the treatment and perception of the patient of his/her health status and the health care received from the Hospital Pharmacy Department (HPD). Method: During a four-month period, from July to October of 2009, a questionnaire was provided to all the patients coming to the Hospital Pharmacy Department to gather their medications, except for those starting their therapies. The patients returning the completed questionnaire at a next visit were provided with the second part, in which they were informed on the monthly cost of their treatments and some questions from the main questionnaire were asked again. Results: 682 questionnaires were provided, of which 240 (35.3%) were returned completed. 223 patients were given the second part, of which 151 (22.1%) were returned. In general, the patients were satisfied with their treatments (90.4%) and with the care provided at the HPD (95.4%), 69.2% had good knowledge of their treatment, and 59.2% considered themselves as good compliers, and 17.5% did not usually consult with the pharmacist at the HPD. The patient's satisfaction analysis before (7.75; SD: 1.90) and after knowing the treatment cost (7.80; SD: 1.91) did not show statistically significant differences, with the exception of those patients derived from the Infectious Disease Department (p = 0.015) that were less satisfied after knowing the cost. Conclusions: The knowledge on the treatment cost could not be related in general with changes in the attitude of the patients towards their treatments, being necessary the design of more profound studies. Besides, it should be recommended to undertake the improvement actions detected by the patients in order to increase the quality of the pharmacy care delivered (AU)

Alopecia areata strontium ranelate universal / Alopecia areata universalis due to strontium ranelate

No disponible

Edema facial por gemfibrozilo / Facial edema due to gemfibrozil

No disponible

No disponible

Chemotherapy dose intensity reductions due to adverse drug reactions in an oncology outpatient setting.

OBJECTIVE: the aim of this study was to establish the incidence of adverse drug reactions (ADRs) that prevent administration of planned dose intensity antineoplastic chemotherapy in clinical practice. METHODS: a retrospective cohort study was made of adult oncology patients who received intravenous chemotherapy in an outpatient ward during 2005. Dose delays, dose reductions, dose omissions, or treatment discontinuations with respect to the planned chemotherapy regimen were obtained, and causes were evaluated to identify ADRs. RESULTS: a total of 532 patients were included, involving the administration of 631 chemotherapy regimens. The total number of cycles evaluated was 3553. The incidence of nonadherence to planned treatment due to ADRs was 12.9% cycles (95% CI: 11.8-14.0). Differences according to patient's age were found, patients younger than 65 years showed higher rates of nonadherence due to ADRs. Myelosuppression was the main cause of dose delays, and gastrointestinal and neurological toxicity were reported as the main causes of dose reductions. CONCLUSIONS: the incidence of ADRs preventing planned dose intensity administration has been estimated. Follow-up of nonadherence to antineoplastic chemotherapy prescriptions can be used to evaluate tolerance in the clinical setting. Continuous evaluation of security in clinical practice provides information on benefits outweighing the deleterious effects in specific patient populations where the available data are limited.